Introduction Access to radiometals suitable for labeling novel molecular imaging agents requires that they be routinely available and inexpensive to obtain. Proximity to a cyclotron center outfitted with solid target hardware, or to an isotope generator for a radiometal of interest is necessary, both of which can be significant hurdles in availability of less common isotopes. Herein, we describe the production of 44Sc, 68Ga, 89Zr, 86Y and 94mTc in a solution target which allows for the production of various radiometallic isotopes, enabling rapid isotope-biomolecule pairing optimization for tracer development. Work on solution targets has also been performed by other groups [e.g. 1, 2]. Material and Methods Solutions containing a high concentration of natural-abundance zinc nitrate, yttrium nitrate, calcium nitrate [3], strontium nitrate or ammonium heptamolybdate [4] were irradiated on a 13 MeV cyclotron using a standard liquid target. Some of the solutions contained additional hydrogen peroxide or nitric acid to improve solubility and reduce pressure rise in the target during irradiation. Yields calculated using theoretical cross sections (EMPIRE [5]) were compared to the measured yields. In addition, we tested a thermo-syphon target design for the production of 44Sc. Chemical separation of the product from the target material was carried out on a remote apparatus modeled after that of Siikanen [6]. Results and Conclusion The proposed approach enabled the production of quantities sufficient for chemical or biological studies for all metals discussed. In the case of 68Ga, activity up to 480 ± 22 MBq was obtained from a one hour run with a beam current of 7 µA, potentially enabling larger scale clinical production. Considering all reactions, the ratio of theoretical saturation yields to experimental yields ranges from 0.8 for 94mTc to 4.4 for 44Sc. The thermo-syphon target exhibited an increase of current on the target by a factor of 2.5 and an increase in yield by a factor of five for the production of 44Sc. Separation methods were developed for all isotopes and separation efficiency ranges from 71 ± 1 % for 94mTc to 99 ± 4 % for 86Y. 44Sc, 68Ga, and 86Y were successfully used in labeling studies with a model 1,4,7,10-tetrazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) chelate, while 89Zr coordination behavior was tested using desferrioxamine-alkyne (DFO-alkyne). In summary, we present a promising new method to produce a suite of radiometals in a liquid target. Future work will continue to expand the list of radiometals and to apply this approach to the development of various peptide, protein and antibody radiotracers.

Introduction Radiometals are finding more and more applications in molecular imaging and targeted therapy. For PET imaging, all the novel radiometals are directly or indirectly produced on cyclotrons. Key step in their production is achieving proper radionuclidic, radiochemical and chemical purity, as well as high specific activity. Automation of the process enhances reproducibility, shortens necessary operations and decreases radiation burden. We have, therefore, developed universal radio-metal automated laboratory workbench (RALW) that is focused on separation processes from solid and liquid (solution) targets via solid phase extraction (SPE). Material and Methods RALW is versatile platform for separation, formulation and simple labeling processes. The following FIG. 1 displays its basic scheme. RALW´s main parts are: two reactors, two selec-tors, peristaltic pump, 3/2 way valves, and separation column. Prime reactor R1 is designed to carry out several functions. It can transport solid target material from shielding container to process position, or handle liquid target filling. In both cases, the reactor is leakagefree up to 5 bars. There are 4 positions available to bring solvents to the reactor 1 or applying on a SPE column according to the separation sequence with use of peristaltic pump. Smart software allows for collecting defined fractions leaving the column, e.g. enriched target matrix and the desired radionuclide, by monitoring activity profile and controlling the splitting valves. The system also minimizes losses during transport of the solvents/fractions to the reactor R2 and the software also controls final volume settings (activity concentration) of the product. Up to three positions are available for bringing solvents/solutions to the reactor R2 for formulation or simple labeling steps like chelation. The system’s hardware is driven by a PLC and I/O cards. The PLC is placed outside the module to avoid radiation damage. The module, PLC and host PC communicate via an Ethernet cable. This solution significantly reduced number of cables connecting the module with other component in the control chain. The PLC is controlled via host PC equipped with userfriendly interface. Results and Conclusion The presented RPLW system is rather versatile tool for separation of metal radionuclides and simple postprocessing (formulation/labelling) of the product in stable environment and easy control mechanisms. The RPLW operating prototype is shown on the FIG. 2.

Introduction Access to radiometals suitable for labeling novel molecular imaging agents requires that they be routinely available and inexpensive to obtain. Proximity to a cyclotron center outfitted with solid target hardware, or to an isotope generator for a radiometal of interest is necessary, both of which can be significant hurdles in availability of less common isotopes. Herein, we describe the production of 44Sc, 68Ga, 89Zr, 86Y and 94mTc in a solution target which allows for the production of various radiometallic isotopes, enabling rapid isotope-biomolecule pairing optimization for tracer development. Work on solution targets has also been performed by other groups [e.g. 1, 2]. Material and Methods Solutions containing a high concentration of natural-abundance zinc nitrate, yttrium nitrate, calcium nitrate [3], strontium nitrate or ammonium heptamolybdate [4] were irradiated on a 13 MeV cyclotron using a standard liquid target. Some of the solutions contained additional hydrogen peroxide or nitric acid to improve solubility and reduce pressure rise in the target during irradiation. Yields calculated using theoretical cross sections (EMPIRE [5]) were compared to the measured yields. In addition, we tested a thermo-syphon target design for the production of 44Sc. Chemical separation of the product from the target material was carried out on a remote apparatus modeled after that of Siikanen [6]. Results and Conclusion The proposed approach enabled the production of quantities sufficient for chemical or biological studies for all metals discussed. In the case of 68Ga, activity up to 480 ± 22 MBq was obtained from a one hour run with a beam current of 7 µA, potentially enabling larger scale clinical production. Considering all reactions, the ratio of theoretical saturation yields to experimental yields ranges from 0.8 for 94mTc to 4.4 for 44Sc. The thermo-syphon target exhibited an increase of current on the target by a factor of 2.5 and an increase in yield by a factor of five for the production of 44Sc. Separation methods were developed for all isotopes and separation efficiency ranges from 71 ± 1 % for 94mTc to 99 ± 4 % for 86Y. 44Sc, 68Ga, and 86Y were successfully used in labeling studies with a model 1,4,7,10-tetrazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) chelate, while 89Zr coordination behavior was tested using desferrioxamine-alkyne (DFO-alkyne). In summary, we present a promising new method to produce a suite of radiometals in a liquid target. Future work will continue to expand the list of radiometals and to apply this approach to the development of various peptide, protein and antibody radiotracers.

Introduction Radiometals are finding more and more applications in molecular imaging and targeted therapy. For PET imaging, all the novel radiometals are directly or indirectly produced on cyclotrons. Key step in their production is achieving proper radionuclidic, radiochemical and chemical purity, as well as high specific activity. Automation of the process enhances reproducibility, shortens necessary operations and decreases radiation burden. We have, therefore, developed universal radio-metal automated laboratory workbench (RALW) that is focused on separation processes from solid and liquid (solution) targets via solid phase extraction (SPE). Material and Methods RALW is versatile platform for separation, formulation and simple labeling processes. The following FIG. 1 displays its basic scheme. RALW´s main parts are: two reactors, two selec-tors, peristaltic pump, 3/2 way valves, and separation column. Prime reactor R1 is designed to carry out several functions. It can transport solid target material from shielding container to process position, or handle liquid target filling. In both cases, the reactor is leakagefree up to 5 bars. There are 4 positions available to bring solvents to the reactor 1 or applying on a SPE column according to the separation sequence with use of peristaltic pump. Smart software allows for collecting defined fractions leaving the column, e.g. enriched target matrix and the desired radionuclide, by monitoring activity profile and controlling the splitting valves. The system also minimizes losses during transport of the solvents/fractions to the reactor R2 and the software also controls final volume settings (activity concentration) of the product. Up to three positions are available for bringing solvents/solutions to the reactor R2 for formulation or simple labeling steps like chelation. The system’s hardware is driven by a PLC and I/O cards. The PLC is placed outside the module to avoid radiation damage. The module, PLC and host PC communicate via an Ethernet cable. This solution significantly reduced number of cables connecting the module with other component in the control chain. The PLC is controlled via host PC equipped with userfriendly interface. Results and Conclusion The presented RPLW system is rather versatile tool for separation of metal radionuclides and simple postprocessing (formulation/labelling) of the product in stable environment and easy control mechanisms. The RPLW operating prototype is shown on the FIG. 2.

Résumé : L’imagerie TEP est une modalité puissante qui permet de suivre d’infimes concentrations de traceurs marqués pour la détection de cancers et d’autres pathologies. Il y a actuellement un intérêt croissant pour le développement de peptides comme outils diagnostiques et de traitement en oncologie. Cet intérêt se justifie entre autres par le fait que les peptides sont tolérants à la présence de chélateurs bifonctionnels ou de groupements prosthétiques pour le marquage avec divers radiométaux (64Cu, T1/2 = 12,7 h, 68Ga, T1/2 = 68 min, etc.) ou le 18F (T1/2 = 109,8 min) sans perte de leur activité biologique. L’objectif des travaux rapportés dans ce document était de développer des outils moléculaires innovateurs et efficaces qui facilitent le marquage de peptides pour l’imagerie TEP. Il s’agit spécifiquement d’un chélateur bifonctionnel et d’une méthode de conjugaison rapide et sélective de groupe prosthétique. Sur un volet, un chélateur bifonctionnel analogue de la lysine avec des ligands méthylhydroxamates a été synthétisé en solution par double bisalkylation. Les résultats préliminaires indiquent une faible chélation avec le Cu(II), mais sont à poursuivre avec les 68Ga et 89Zr. Pour le second volet de radiomarquage au 18F, les procédures synthétiques ont été optimisées en deux étapes, soient le marquage du groupe prothétique et sa conjugaison au peptide. Tout d’abord, des conditions de marquage par une réaction de SNAr en présence de 18F- ont été développées pour donner le groupe prosthétique 18F-thioester nécessaire à la conjugaison. Par la suite, sa conjugaison au peptide par la réaction de ligation chémosélective, ce qui implique trois étapes 1) une transthioestérification favorisée entre les groupements thioester et thiol des segments de peptides; 2) un réarrangement irréversible de l’intermédiaire thioester en N-(oxyalkyl)amide, suivi; 3) du clivage de l’auxiliaire. Par les présents travaux, il a été prouvé que la nouvelle méthodologie en un seul pot réactionnel accélère la réaction et permet le marquage au 18F de peptides non protégés, limitant ainsi les réactions secondaires et le nombre d’étapes après le marquage des peptides. La conjugaison du groupe prothétique à un composé et un peptide modèle se produit en 26-55 min comparativement aux 48 h des conditions originales rapportées. La méthode proposée permet également le marquage de peptides non protégés. Dans le futur, le chélateur bifonctionnel et le groupe prothétique seront conjugués à différents dérivés peptidiques ciblant des récepteurs impliqués dans le cancer et des tests de compétition, de saturation, de biodistribution et d’imagerie µTEP seront effectués. / Abstract : PET is a powerful imaging modality that follows tiny labeled tracer concentrations for the detection of cancer and other pathologies. There currently is a growing interest for the development of peptides as diagnostic and treatment tools in oncology. This interest is justified by the fact that peptides are tolerant to the presence of bifunctionnal chelators or prosthetic groups for labeling with many radiometals (64Cu, T1/2 = 12,7 h, 68Ga, T1/2 = 68 min, etc.) or 18F (T1/2 = 109,8 min), without losing their biological activity. The objective of the work reported in this document was to develop innovative and efficient molecular tools that facilitate peptide labeling for PET imaging. Specifically, they are a bifunctionnal chelator and a fast and selective prosthetic group conjugation method. On the first aspect, a lysine analogue bifunctionnal chelator bearing methylhydroxamate ligands was synthesized in solution through a double bisalkylation. The preliminary results show a weak Cu(II) chelation, but they are to be pushed forward with 68Ga and 89Zr. On the second aspect of 18F radiolabeling, synthetic procedures were optimised for two steps, which are the prosthetic group’s labeling and its conjugation to the peptide. First, the labeling conditions for a SNAr reaction with 18F- were developed, to yield the necessary 18F-thioester prosthetic group. Then, its conjugation to the peptide by the chemical ligation reaction through its three steps 1) a favored transthioesterification between the thioester and thiol peptide segments; 2) an irreversible rearrangement of the thioester intermediate to a N-(oxyalkyl)amide, followed; 3) the auxiliary cleavage. By this work, it has been proven that the new one pot methodology accelerates the reaction and allows the 18F labeling of unprotected peptides, which limits secondary reactions and the number of post peptide labeling steps. The prosthetic group conjugation to both model compound and peptide takes place in 26-55 min, compared to the 48 h initially reported. The proposed method also allows the labeling of unprotected peptides. In the future, the bifunctionnal chelator and the prosthetic group will be conjugated to different peptide derivatives that target cancer implied receptors and competition, saturation, biodistribution and µPET imaging assays will be performed.